title: [Screening and management of bipolar disorders: methodology].
authors.affiliation: pmllorca@chu-clermontferrand.fr
authors.forename: Pierre-Michel
authors.initials: PM
authors.lastname: Llorca
authors.forename: Philippe
authors.initials: P
authors.lastname: Courtet
authors.forename: Patrick
authors.initials: P
authors.lastname: Martin
authors.forename: Mocrane
authors.initials: M
authors.lastname: Abbar
authors.forename: Christian
authors.initials: C
authors.lastname: Gay
authors.forename: Jean-Albert
authors.initials: JA
authors.lastname: Meynard
authors.forename: Franck
authors.initials: F
authors.lastname: Baylé
authors.forename: Michel
authors.initials: M
authors.lastname: Hamon
authors.forename: Christophe
authors.initials: C
authors.lastname: Lançon
authors.forename: Florence
authors.initials: F
authors.lastname: Thibaut
authors.forename: Pierre
authors.initials: P
authors.lastname: Thomas
authors.forename: Sylvie
authors.initials: S
authors.lastname: Lancrenon
authors.forename: Sébastien
authors.initials: S
authors.lastname: Guillaume
authors.forename: Ludovic
authors.initials: L
authors.lastname: Samalin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000523:psychology; D019317:Evidence-Based Medicine; D005260:Female; D005602:France; D006801:Humans; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D018692:Antimanic Agents; D011619:Psychotropic Drugs